Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey

BACKGROUND: During the current SARS‐CoV‐2 pandemic it is important to identify risk factors for COVID‐19. Registry studies are providing growing evidence on the elevated risk of mortality from COVID‐19 in patients with chronic liver disease, especially in advanced stages. Results may, however, have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecher, Britta Franziska, Buescher, Gustav, Willemse, José, Walmsley, Martine, Taylor, Alison, Leburgue, Angela, Schramm, Christoph, Lohse, Ansgar W., Sebode, Marcial
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242670/
https://www.ncbi.nlm.nih.gov/pubmed/34105883
http://dx.doi.org/10.1002/ueg2.12100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242670/
https://www.ncbi.nlm.nih.gov/pubmed/34105883
http://dx.doi.org/10.1002/ueg2.12100

Ejemplares similares